These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 22197519)

  • 1. Within-person study designs had lower precision and greater susceptibility to bias because of trends in exposure than cohort and nested case-control designs.
    Nicholas JM; Grieve AP; Gulliford MC
    J Clin Epidemiol; 2012 Apr; 65(4):384-93. PubMed ID: 22197519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Within-person vs. traditional study designs: how to evaluate study designs?
    Chen H; Nembhard WN; Stockwell HG
    J Clin Epidemiol; 2013 Mar; 66(3):350-1. PubMed ID: 22959590
    [No Abstract]   [Full Text] [Related]  

  • 3. Limitations of within-person study designs. In reply.
    Nicholas JM; Grieve AP; Gulliford MC
    J Clin Epidemiol; 2013 Dec; 66(12):1429. PubMed ID: 24012152
    [No Abstract]   [Full Text] [Related]  

  • 4. Censoring on outcome is not valid in self-controlled case series studies.
    Farrington P
    J Clin Epidemiol; 2013 Dec; 66(12):1428-9. PubMed ID: 24012151
    [No Abstract]   [Full Text] [Related]  

  • 5. Thiazolidinediones and the risk of incident strokes in patients with type 2 diabetes: a nested case-control study.
    Azoulay L; Schneider-Lindner V; Dell'aniello S; Filion KB; Suissa S
    Pharmacoepidemiol Drug Saf; 2010 Apr; 19(4):343-50. PubMed ID: 19998318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The risk of myopathy associated with thiazolidinediones and statins in patients with type 2 diabetes: a nested case-control analysis.
    Koro CE; Sowell MO; Stender M; Qizilbash N
    Clin Ther; 2008 Mar; 30(3):535-42. PubMed ID: 18405791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Thiazolidinediones and skeletal health].
    Meier C; Bodmer M; Meier CR; Kraenzlin ME
    Rev Med Suisse; 2009 Jun; 5(207):1309-10, 1312-3. PubMed ID: 19626930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial metformin or sulphonylurea exposure and cancer occurrence among patients with type 2 diabetes mellitus.
    Qiu H; Rhoads GG; Berlin JA; Marcella SW; Demissie K
    Diabetes Obes Metab; 2013 Apr; 15(4):349-57. PubMed ID: 23137378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between thiazolidinedione treatment and risk of macular edema among patients with type 2 diabetes.
    Idris I; Warren G; Donnelly R
    Arch Intern Med; 2012 Jul; 172(13):1005-11. PubMed ID: 22688528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of thiazolidinediones and fracture risk.
    Meier C; Kraenzlin ME; Bodmer M; Jick SS; Jick H; Meier CR
    Arch Intern Med; 2008 Apr; 168(8):820-5. PubMed ID: 18443256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thiazolidinediones and heart failure: a teleo-analysis.
    Singh S; Loke YK; Furberg CD
    Diabetes Care; 2007 Aug; 30(8):2148-53. PubMed ID: 17536074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thiazolidinediones and the risk of incident congestive heart failure among patients with type 2 diabetes mellitus.
    Filion KB; Joseph L; Boivin JF; Suissa S; Brophy JM
    Pharmacoepidemiol Drug Saf; 2011 Aug; 20(8):785-96. PubMed ID: 21671441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rosiglitazone and pioglitazone increase fracture risk in women and men with type 2 diabetes.
    Aubert RE; Herrera V; Chen W; Haffner SM; Pendergrass M
    Diabetes Obes Metab; 2010 Aug; 12(8):716-21. PubMed ID: 20590749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycemic Control with Thiazolidinedione Is Associated with Fracture of T2DM Patients.
    Chen HH; Horng MH; Yeh SY; Lin IC; Yeh CJ; Muo CH; Sung FC; Kao CH
    PLoS One; 2015; 10(8):e0135530. PubMed ID: 26317995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of heart failure in patients with recent-onset type 2 diabetes: population-based cohort study.
    Leung AA; Eurich DT; Lamb DA; Majumdar SR; Johnson JA; Blackburn DF; McAlister FA
    J Card Fail; 2009 Mar; 15(2):152-7. PubMed ID: 19254675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between congestive heart failure and hospitalization in patients with type 2 diabetes mellitus receiving treatment with insulin or pioglitazone: a retrospective data analysis.
    Rajagopalan R; Rosenson RS; Fernandes AW; Khan M; Murray FT
    Clin Ther; 2004 Sep; 26(9):1400-10. PubMed ID: 15531002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of thiazolidinediones with liver cancer and colorectal cancer in type 2 diabetes mellitus.
    Chang CH; Lin JW; Wu LC; Lai MS; Chuang LM; Chan KA
    Hepatology; 2012 May; 55(5):1462-72. PubMed ID: 22135104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thiazolidinediones and fractures in men and women.
    Dormuth CR; Carney G; Carleton B; Bassett K; Wright JM
    Arch Intern Med; 2009 Aug; 169(15):1395-402. PubMed ID: 19667303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of acute myocardial infarction in patients treated with thiazolidinediones or other antidiabetic medications.
    Stockl KM; Le L; Zhang S; Harada AS
    Pharmacoepidemiol Drug Saf; 2009 Feb; 18(2):166-74. PubMed ID: 19109802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thiazolidinedione use and the longitudinal risk of fractures in patients with type 2 diabetes mellitus.
    Habib ZA; Havstad SL; Wells K; Divine G; Pladevall M; Williams LK
    J Clin Endocrinol Metab; 2010 Feb; 95(2):592-600. PubMed ID: 20061432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.